ALPS Advisors’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14,058
| Closed | -$304K | – | 1161 |
|
|
2022
Q4 | $304K | Buy |
14,058
+3,310
| +31% | +$71.5K | ﹤0.01% | 882 |
|
|
2022
Q3 | $208K | Sell |
10,748
-864
| -7% | -$16.7K | ﹤0.01% | 1001 |
|
|
2022
Q2 | $231K | Sell |
11,612
-8,288
| -42% | -$165K | ﹤0.01% | 974 |
|
|
2022
Q1 | $594K | Sell |
19,900
-2,407
| -11% | -$71.8K | 0.01% | 410 |
|
|
2021
Q4 | $520K | Sell |
22,307
-1,288
| -5% | -$30K | 0.01% | 488 |
|
|
2021
Q3 | $736K | Sell |
23,595
-1,680
| -7% | -$52.4K | 0.01% | 425 |
|
|
2021
Q2 | $889K | Sell |
25,275
-9,306
| -27% | -$327K | 0.01% | 416 |
|
|
2021
Q1 | $1.22M | Buy |
34,581
+256
| +0.7% | +$9.02K | 0.01% | 377 |
|
|
2020
Q4 | $1.29M | Buy |
34,325
+10,110
| +42% | +$379K | 0.01% | 362 |
|
|
2020
Q3 | $808K | Buy |
24,215
+3,783
| +19% | +$126K | 0.01% | 371 |
|
|
2020
Q2 | $541K | Sell |
20,432
-6,095
| -23% | -$161K | 0.01% | 440 |
|
|
2020
Q1 | $434K | Buy |
26,527
+771
| +3% | +$12.6K | 0.01% | 452 |
|
|
2019
Q4 | $655K | Buy |
25,756
+418
| +2% | +$10.6K | 0.01% | 473 |
|
|
2019
Q3 | $507K | Buy |
25,338
+148
| +0.6% | +$2.96K | ﹤0.01% | 498 |
|
|
2019
Q2 | $812K | Sell |
25,190
-3,722
| -13% | -$120K | 0.01% | 376 |
|
|
2019
Q1 | $931K | Buy |
28,912
+1,253
| +5% | +$40.3K | 0.01% | 347 |
|
|
2018
Q4 | $678K | Buy |
27,659
+6,478
| +31% | +$159K | 0.01% | 403 |
|
|
2018
Q3 | $698K | Buy |
21,181
+3,924
| +23% | +$129K | ﹤0.01% | 473 |
|
|
2018
Q2 | $613K | Buy |
+17,257
| New | +$613K | ﹤0.01% | 481 |
|